Neonatology Unit. Reina Sofia University Hospital; Pediatric Research Unit, Maimónides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, Córdoba, Spain.
Maimónides Biomedical Research Institute of Córdoba (IMIBIC), University of Córdoba, Córdoba, Spain.
Eur J Pediatr. 2020 Aug;179(8):1255-1265. doi: 10.1007/s00431-020-03613-8. Epub 2020 Feb 24.
Extrauterine growth restriction (EUGR) is a frequent morbidity of preterm infants that can affect short- and long-term prognosis as it involves different EUGR-related alterations in growth and neurological development, as well as cardiometabolic risk. However, knowledge about the prognosis of EUGR is scarce. Thus, the objective of this study is to review the evidence regarding EUGR-related comorbidities in childhood by a systematic approach. This review was carried out using the Joanna Briggs Institute Reviewers' Manual Methodology and the PRISMA (Preferred Reporting Items for Systematic Review and Meta-Analyses)-Search Extension for scoping review. The MEDLINE and EMBASE databases were used to identify papers published until September 2017. Twenty-four publications were included and 19 examined cohort studies. EUGR is mainly associated with (1) lower weight, length, and head circumference measures in childhood; (2) poor neurodevelopment; and (3) alterations in cardiometabolic risk markers. The definition for EUGR and the populations studied differ among authors.Conclusion: EUGR is mainly associated with poor growth and neurodevelopment, as well as with cardiometabolic alterations in childhood. Evidence is based on observational studies with variability in the included populations due to the lack of consensus regarding the definition for EUGR. Finding a gold standard definition becomes paramount in order to select phenotypes at risk later in life. What is known? • EUGR is a frequent condition of preterm infants. Up to date little is known about the effect of the metabolic programming on prognosis. What is new? • The available evidence, which is based on observational studies with variability in the population and the existing different definitions for EUGR, do not enable appropriate data collection. EUGR is mainly associated with poor growth and neurodevelopment, as well as with cardiometabolic alterations in childhood.
宫外生长受限(EUGR)是早产儿常见的发病率,它会影响短期和长期预后,因为它涉及到生长和神经发育以及心脏代谢风险的不同 EUGR 相关改变。然而,关于 EUGR 的预后知识还很缺乏。因此,本研究的目的是通过系统的方法回顾有关 EUGR 相关并发症的证据。本综述使用 Joanna Briggs 研究所评审员手册方法和 PRISMA(系统评价和荟萃分析的首选报告项目)扩展搜索进行了综述。使用 MEDLINE 和 EMBASE 数据库来确定截至 2017 年 9 月发表的论文。共纳入 24 篇文献,其中 19 篇为队列研究。EUGR 主要与(1)儿童时期的体重、长度和头围测量值较低;(2)神经发育不良;(3)心脏代谢风险标志物的改变有关。EUGR 的定义和研究人群在作者之间存在差异。结论:EUGR 主要与儿童时期的生长和神经发育不良以及心脏代谢改变有关。证据基于观察性研究,由于对 EUGR 定义缺乏共识,纳入人群存在差异。寻找黄金标准的定义变得至关重要,以便选择以后生活中处于风险状态的表型。已知的?•EUGR 是早产儿的常见病症。目前,关于代谢编程对预后的影响知之甚少。新的?•现有的证据基于观察性研究,人群存在差异,并且存在不同的 EUGR 定义,因此无法进行适当的数据收集。EUGR 主要与儿童时期的生长和神经发育不良以及心脏代谢改变有关。